Osteopathic Treatment to Alcohol Withdrawal Syndrome

Alcohol Withdrawal Clinical Trial

— OSTEOOL  

Official title:

Contribution of Osteopathic Treatment to Alcohol Withdrawal Syndrome in Hospitalized Adult Patients

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03916939
• Other study ID #: OSTEOOL
• Status: Recruiting
• Phase: N/A
• Start date: September 26, 2018
• Est. completion date: February 13, 2024

Study information

• Verified date: June 2022
• Source: Centre Hospitalier Intercommunal Creteil
• Contact: camille JUNG, MD
• Phone: 01457022268
• Email: camille.jung[@]chicreteil.fr
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The alcohol withdrawal syndrome has a hierarchical symptomatology depending on the severity (minor, moderate or severe). These signs express a state of psychic, behavioral and physical deprivation.

The management of withdrawal syndrome involves the establishment of pharmacological and psychosocial interventions.

Osteopathy is an exclusively manual practice whose purpose is to overcome the dysfunction of mobility of tissues of the human body. It can be used as a complementary treatment when a specific support is put in place. The purpose of this study is to examine the effectiveness of osteopathy in reducing alcohol withdrawal symptoms in adult patients.

Description:

The use of osteopathic techniques for facial equilibration decreases the severity of withdrawal symptoms experienced by patients hospitalized in a weekday hospital.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 50
• Est. completion date: February 13, 2024
• Est. primary completion date: December 13, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria :

• Age> 18 years

• Patient hospitalized for a programmed alcohol withdrawal

• Patient not abstinent with alcohol before hospitalization

• Signed informed consent

Exclusion Criteria :

• Minor patient

• Patient with an addiction other than alcohol (except tobacco and benzodiazepines)

• Previous participation in the OSTEOOL study

Related Conditions & MeSH terms

• Alcohol Withdrawal
• Substance Withdrawal Syndrome

Intervention

Other:
• osteopathy
osteopathy treatment
• simulated osteopathy
simulated osteopathic sessions

Locations

Country	Name	City	State
France	Chi Creteil	Creteil

Sponsors (2)

Lead Sponsor	Collaborator
Centre Hospitalier Intercommunal Creteil	Ecole Supérieur d'Ostéopathie

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Cushman score (0 to 27)	comparison between the two groupe of the cushamn socre between 11:30 am and 00:00 pm. questionary for alcohol dependency	Day one
Secondary	CIWA Ar (Clinicial Institute Withdrawal Assessment - Alcohol Revised) test (0 to 67)	comparison between the two groups with this questionary for alcohol withdrawal	day 0
Secondary	CIWA Ar test (0 to 67)	comparison between the two groupe with this questionary for alcohol withdrawal	day 1
Secondary	CIWA Ar test (0 to 67)	compariason between the two groups with this questionary for alcohol withdrawal	day 2
Secondary	CIWA Ar test (0 to 67)	comparison between the two groups with this questionary for alcohol withdrawal	day 3
Secondary	CIWA Ar test (0 to 67)	comparison between the two groups with this questionary for alcohol withdrawal	day 4
Secondary	cardiac frequency (beat per minute)	mesurement of cardiac frequency and compaaison between the two groups	day 1
Secondary	cardiac frequency (beat per minute)	mesurement of cardiac frequency and comparison between the two groups	day 3
Secondary	cardiac frequency (beat per minute)	measurement of cardiac frequency and comparison between the two groups	day 4
Secondary	quality sleep scale (0 to 5)	comparison between the two groups with sleep score	day 0
Secondary	quality sleep scale (0 to 5)	comparison between the two groups with sleep score	day 1
Secondary	quality sleep scale (0 to 5)	comparison between the two groups with sleep score	day 2
Secondary	quality sleep scale (0 to 5)	comparison between the two groups with sleep score	day 3
Secondary	quality sleep scale (0 to 5)	comparison between the two groups with sleep score	day 4
Secondary	quantity of benzodiazepine mg per 24 hours	comparison between the two groups of benzodiazepin use	day 2
Secondary	quantity of benzodiazepine (mg per 24 hours)	comparison between the two groups of benzodiazepin use	day 3
Secondary	quantity of benzodiazepine (mg per 24 hours)	comparison betwenn the two groups of benzodiazepin use	day 4
Secondary	Cushmamn score (0 to 27)	comparison between the two groups of the Cushamn score between 11:30 am and 00:00 pm	day 3